Made for the UK. Informed by evidence.Our editorial promise
INTERNATIONAL CONTEXT FOR UK READERS

Obesity care in Europe

For UK readers, Europe provides useful context for how other health systems assess obesity treatment. European authorisation and national reimbursement are separate decisions. The UK has its own regulator and four NHS systems; rules in an EU country do not establish eligibility, funding or availability in the UK.

Read the funding decision as well as the licence

A licensed treatment may be available only through private prescribing, or publicly funded for a narrower group. Compare the indication, the eligible patient group and any specialist-service requirement before comparing costs.

Watch for policy changes

France's restricted reimbursement pathway and Ireland's ongoing reimbursement decision illustrate why an older country guide can mislead. Each page links to the primary sources used and distinguishes a recommendation from implemented access.

Explore the country guides

5 guides

United Kingdom ↗

Start here for UK care. Licensed weight-management medicines are available, but NHS access depends on your nation, local pathway and clinical criteria. Private treatment requires its own assessment. Compare ongoing care and GBP costs after establishing which route is appropriate.

Read the country guide →

Ireland ↗

Ireland illustrates the gap between a medicine being prescribed and a reimbursement decision being implemented. The HSE's patient guidance and the latest NCPE assessment answer different parts of that question.

Read the country guide →

Germany ↗

In Germany, approval for weight management and statutory health-insurance reimbursement are distinct. The legal exclusion affecting weight-loss medicines can matter more to the patient's bill than the European licence.

Read the country guide →

France ↗

France introduced restricted reimbursement for Wegovy and Mounjaro in June 2026. The permitted prescribing indication is broader than the group eligible for reimbursement, and the paperwork is part of the pathway.

Read the country guide →

Spain ↗

Spain provides separate public sources for a medicine's technical information and its national funding status. Reading both avoids confusing an authorised weight-management treatment with an SNS-funded prescription.

Read the country guide →